November 02, 2026
Investors of now-bankrupt vaccine company Gritstone Bio Inc. have asked a California federal court to grant final approval to a $6 million settlement resolving claims that its former CEO failed to disclose the company's inability to carry out a $423 million government contract for COVID-19 vaccine research it was granted in 2023.